Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Nephrology

Pharmacology/kinetics

Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: A multicentre, prospective cohort study

Anaesthesia | Jul 17, 2018 Pharmacology/kinetics

NT-proBNP predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk

Diabetes, Obesity and Metabolism | Jul 14, 2018 Pharmacology/kinetics

Effect of steroid pulse therapy on post-transplant immunoglobulin A nephropathy

Nephrology | Jul 12, 2018 Pharmacology/kinetics

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: Subanalysis of the EMPA-REG OUTCOME randomised trial

Diabetologia - Clinical and Experimental Diabetes and Metabolism | Jul 11, 2018 Pharmacology/kinetics

Risk of acute kidney injury following community prescription of antibiotics: Self-controlled case series

Nephrology Dialysis Transplantation | Jul 04, 2018 Pharmacology/kinetics

Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy

Nephrology | Jul 03, 2018 Pharmacology/kinetics

End stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: A Taiwanese Nationwide Cohort Study

Internal Medicine Journal | Jul 02, 2018 Pharmacology/kinetics

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study

Diabetes, Obesity and Metabolism | Jul 01, 2018 Pharmacology/kinetics

Eculizumab treatment in severe pediatric STEC-HUS: A multicenter retrospective study

Pediatric Nephrology | Jun 30, 2018 Pharmacology/kinetics

Intravenous epoetin alfa-epbx vs epoetin alfa for treatment of anemia in end-stage kidney disease

Clinical Journal of the American Society of Nephrology | Jun 29, 2018 Pharmacology/kinetics

« Prev 1 … 57 58 59 60 61 … 77 Next »

Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: A multicentre, prospective cohort study

NT-proBNP predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk

Effect of steroid pulse therapy on post-transplant immunoglobulin A nephropathy

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: Subanalysis of the EMPA-REG OUTCOME randomised trial

Risk of acute kidney injury following community prescription of antibiotics: Self-controlled case series

Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy

End stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: A Taiwanese Nationwide Cohort Study

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study

Eculizumab treatment in severe pediatric STEC-HUS: A multicenter retrospective study

Intravenous epoetin alfa-epbx vs epoetin alfa for treatment of anemia in end-stage kidney disease

Optimising Caesarean Section Practices

New Treatment in Uveitis

Environmental Pollution and Lifestyle Disorders: An Emerging Global Challenge

Anaemia: Types and Management

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: A multicentre, prospective cohort study

NT-proBNP predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk

Effect of steroid pulse therapy on post-transplant immunoglobulin A nephropathy

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: Subanalysis of the EMPA-REG OUTCOME randomised trial

Risk of acute kidney injury following community prescription of antibiotics: Self-controlled case series

Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy

End stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: A Taiwanese Nationwide Cohort Study

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study

Eculizumab treatment in severe pediatric STEC-HUS: A multicenter retrospective study

Intravenous epoetin alfa-epbx vs epoetin alfa for treatment of anemia in end-stage kidney disease

Optimising Caesarean Section Practices

New Treatment in Uveitis

Environmental Pollution and Lifestyle Disorders: An Emerging Global Challenge

Anaemia: Types and Management

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Select Specialty

Select Topic